Biotech Co. To Face Amended Investor Suit Over COVID Test
A California federal judge has declined to dismiss an amended investor complaint against a biotech company over issues with its COVID-19 test rollout, holding the revised suit plausibly alleges the defendants...To view the full article, register now.
Already a subscriber? Click here to view full article